Are IBB and IJT in the same category?

IBB is a thematic ETF and IJT is a stock ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.

Which returned more over the last year, IBB or IJT?

In the year to Oct 28, 2026, with distributions reinvested, IBB returned +37.5% and IJT +15.4%.

Which is cheaper, IBB or IJT?

IJT is cheaper, by 0.26 percentage points a year. That is about $26 on $10,000 held for a year. Fees come from each fund's prospectus.

How much do IBB and IJT overlap with the S&P 500?

By their latest filed holdings, 40% of IBB and 0% of IJT by weight is stocks the S&P 500 already holds.

Data as of Oct 28, 2026.

Across categories

IBB vs IJT: Differences, Returns & Fees

Share on X Download as PDF

Over the year to Oct 28, 2026, IBB returned +37.5% to IJT's +15.4%, and IJT charges 0.18% to IBB's 0.44%.

askIQ about this page

askIQ about IBB and IJT

Net assets on Oct 27, 2026: $11.0bn for iShares Biotechnology ETF and $7.5bn for iShares S&P Small-Cap 600 Growth ETF.

IBB on its own →IJT on its own →

At a glance

+37.5%

IBB total return, 1 year

+15.4%

IJT total return, 1 year

0.44%

IBB expense ratio

0.18%

IJT expense ratio

Pair scorecard

IJT costs 0.26 points a year less; their one-year returns differ by 22.1 points; IBB is 1.5 times larger.

IBB vs IJT: Differences, Returns & Fees
Measure	IBB	IJT
Return
Measure	IBB	IJT
Total return, 1 year	+37.5%	+15.4%
Drawdown
Measure	IBB	IJT
Below its high		8.2%, high on Aug 4, 2026
Benchmark
Measure	IBB	IJT
What it tracks	Biotech	S&P SmallCap 600 Growth Index
Cost and size
Measure	IBB	IJT
Expense ratio	0.44%	0.18%
Net assets, as of Oct 27, 2026	$11.0bn	$7.5bn
Active share vs the S&P 500	99%
Holdings
Measure	IBB	IJT
Holdings in common	3%
Top ten holdings, share of the fund	50%	9.6%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

By the books each fund has filed, IBB and IJT hold 3% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

50%

0 half 100%

half

3% in common

Positions both hold · largest shared weight first IBB IJT

PROTAGONIST THERAPEUTICS 0.60% 1.11%

ALKERMES 0.50% 0.90%

PTC THERAPEUTICS 0.34% 0.63%

VERACYTE 0.28% 0.49%

ACADIA PHARMACEUTICALS 0.24% 0.32%

ARCUTIS BIOTHERAPEUTICS 0.24% 0.44%

ADMA BIOLOGICS 0.17% 0.30%

VERICEL 0.15% 0.27%

SAREPTA THERAPEUTICS 0.13% 0.15%

ARCUS BIOSCIENCES 0.11% 0.15%

VIR BIOTECHNOLOGY 0.11% 0.07%

OMNIAB INC $12.50 VESTING Prvt 0.00% 0.00%

Only in one fund ↓

Only in IBB

GILEAD SCIENCES 8.56%

AMGEN INC 8.20%

VERTEX PHARMACEUTICALS 7.53%

REGENERON PHARMACEUTICALS 5.64%

MODERNA 5.29%

NATERA 3.85%

ARGENX SE ADR 3.42%

ILLUMINA INC 2.93%

Only in IJT

VIASAT INC 1.18%

RYMAN HOSPITALITY PROPERTIES REIT 1.10%

TG THERAPEUTICS 0.97%

ETSY 0.91%

GLAUKOS 0.90%

ZURN ELKAY WATER SOLUTIONS CORP 0.88%

FEDERAL SIGNAL CORP 0.86%

ARMSTRONG WORLD INDUSTRIES 0.80%

Check overlap with more funds →

Side by side

IBB iShares Biotechnology ETF IJT iShares S&P Small-Cap 600 Growth ETF

Where it sits Thematic ETF Stock ETF

Issuer iShares iShares

What it is Biotech Tracks the S&P Small-Cap 600 Growth

Total return, 1 year +37.5% +15.4%

Its benchmark over the same days not measured +15.6% (SLYG)

Gap to its benchmark not measured −0.2 pts vs SLYG

Expense ratio 0.44% 0.18%

Already in the S&P 500 40.2% 0.0%

Holdings 245 369

Net assets, as of Oct 27, 2026 $11.0bn $7.5bn

IBB and IJT on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

About each fund

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

IJT

IJT tracks the S&P Small-Cap 600 Growth. Over the year to Oct 28, 2026 it returned +15.4% with distributions reinvested, against +15.6% for its benchmark, the S&P SmallCap 600 Growth Index. The prospectus expense ratio is 0.18% a year. By its holdings published by its issuer for Oct 27, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 369 positions, with the top ten at 9.6%. It sat 8.2% below its high of Aug 4, 2026 on Oct 28, 2026.

Questions people ask

Are IBB and IJT in the same category?: IBB is a thematic ETF and IJT is a stock ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, IBB or IJT?: In the year to Oct 28, 2026, with distributions reinvested, IBB returned +37.5% and IJT +15.4%.
Which is cheaper, IBB or IJT?: IJT is cheaper, by 0.26 percentage points a year. That is about $26 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do IBB and IJT overlap with the S&P 500?: By their latest filed holdings, 40% of IBB and 0% of IJT by weight is stocks the S&P 500 already holds.

Other comparisons

IBB vs VTWO IBB vs IWC IBB vs IJR IBB vs IWM IJT vs XBI BITO vs IJT CGBL vs IJT HGER vs IJT

Where to next

IBB on its own →IJT on its own →Hold both: look the portfolio through →Rankings →IBB dividend history →IBB holdings →IJT dividend history →IJT holdings →Standards and sources →

Sources and dates

IBB and IJT filings on SEC EDGAR ↗

IBB and IJT prospectus with the expense ratio (SEC) ↗

iShares page for IBB ↗

iShares page for IJT ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Cite this pageCitation, APA and Markdown

ETFIQ, IBB against IJT, data as of Oct 28, 2026. https://etfiq.com/compare/any/ibb-vs-ijt

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.